Categories
Tags
Authors: Calusic M, Marcec R, Luksa L, Jurkovic I, Kovac N, Likic R PMID: 34719789 PMCID: PMC8653355 DOI: 10.1111/bcp.15126 Abstract Aims: Fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) and sigma-1 receptor agonist, has so far shown promise in the prevention of COVID-19 progression as an early treatment option in three trials. The aim of this [...]
Categories: I-CARE Early Covid, MATH+
Tags: COVID-19, Fluvoxamine
Authors:Lips P, de Jongh RT, van schoor NM. PMID:PMC8674774 doi: 10.1002/jbm4.10585 Abstract Vitamin D status varies across all continents and countries. Vitamin D status usually is adequate in Latin America and Australia, but in contrast it is very low in the Middle East and some countries in Asia. Trends in vitamin D status, whether it [...]
Categories: I-PREVENT
Tags:
Auhtors: Gopukumar K, Thanawala S, Somepalli V, Rao TSS, Thamatam VB, Chauhan S PMID: 34858513 PMCID: PMC8632422 DOI: 10.1155/2021/8254344 Abstract Background: The global prevalence of stress is increasing. Stress adversely affects cognitive ability, sleep quality, and overall psychological well-being. Ashwagandha (Withania somnifera (L.) Dunal), an essential medicine in Ayurveda, is reportedly beneficial in reducing stress [...]
Categories: Cancer Care
Tags: Ashwagandha
Auhtors: Abrams HR, Durbin S, Huang CX, Johnson SF, Nayak RK, Zahner GJ, Peppercorn J PMID: 34850932 DOI: 10.1093/tbm/ibab091 Abstract Financial toxicity describes the financial burden and distress that can arise for patients, and their family members, as a result of cancer treatment. It includes direct out-of-pocket costs for treatment and indirect costs such as [...]
Categories: Cancer Care
Tags: Cancer
Authors: Kiprov DD, Herskowitz A, Kim D, Lieb M, Liu C, Watanabe E PMID: 35464182 PMCID: PMC9021669 DOI: 10.12688/f1000research.74534.2 Abstract Many patients with COVID-19 experience a range of debilitating symptoms months after being infected, a syndrome termed long-haul COVID. A 68-year-old male presented with lung opacity, fatigue, physical and cognitive weaknesses, loss of smell and [...]
Categories: I-RECOVER Post-Vaccine
Tags: COVID-19, Plasmapheresis
Authors:Seven B, Gunduz O, Ozgu-Erdinc AS, Sahin D, Moraloglu O, Keskin HL. PMID:34812699 DOI: 10.1080/14767058.2021.2005564 Abstract Objective: To evaluate the relationship between 25-hydroxy vitamin D (25(OH)D) levels and disease severity in hospitalized COVID-19 positive pregnant women. Methods: The COVID-19 (+) pregnant women (confirmed by PCR test) were classified as asymptomatic, mild symptomatic, and severe disease [...]
Categories: I-PREVENT
Tags:
Authors: Abrams RM, Simpson DM, Navis A, Jette N, Zhou L PMID: 34766365 PMCID: PMC8661991 DOI: 10.1002/mus.27458 Abstract Introduction/aims: The development and persistence of neurological symptoms following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is referred to as "long-haul" syndrome. We aimed to determine whether small fiber neuropathy (SFN) was associated with SARS-CoV-2 infection. [...]
Categories: I-RECOVER Post-Vaccine
Authors: Robbins T, Gonevski M, Clark C, Sharma K, Magar A PMID: 34862223 PMCID: PMC8806311 DOI: 10.7861/clinmed.2021-0462 Abstract Background: Long COVID is a common occurrence following COVID-19 infection. The most common symptom reported is fatigue. Limited interventional treatment options exist. We report the first evaluation of hyperbaric oxygen therapy (HBOT) for long COVID treatment. Methods: [...]
Categories: I-RECOVER Post-Vaccine
Authors: Ndeupen S, Qin Z, Jacobsen S, Bouteau A, Estanbouli H, Igyarto BZ PMID: 34841223 PMCID: PMC8604799 DOI: 10.1016/j.isci.2021.103479 Abstract Vaccines based on mRNA-containing lipid nanoparticles (LNPs) are a promising new platform used by two leading vaccines against COVID-19. Clinical trials and ongoing vaccinations present with varying degrees of protection levels and side effects. However, [...]
Categories: I-RECOVER Post-Vaccine
Tags: Inflammation, mRNA
Vitamin D status varies across all continents and countries. Vitamin D status usually is adequate in Latin America and Australia, but in contrast it is very low in the Middle East and some countries in Asia. Trends in vitamin D status, whether it improves or declines over the years, carry important messages.
Categories:
Tags: 25‐HYDROXY VITAMIN D


